IMMUNOHISTOCHEMICAL BIOMARKERS IN EC 129 5 A. B. Figure S1A-B Figure S1 A-B. A. DSS for the ESMO-ESGO-ESTRO risk groups. B. DSS for the ESMO-ESGO-ESTRO ‘high and advanced/metastatic’ risk group in relation to p53, L1CAM and ER/PR expression. Abbreviations: ESMO-ESGO-ESTRO, European Society for Medical Oncology - European Society of Gynaecological Oncology - European SocieTy for Radiotherapy & Oncology; ER/PR, estrogen receptor/progesterone receptor; L1CAM, L1 cell-adhesion molecule; p53abn, p53-abnormal; p53wt, p53-wildtype; DSS, disease-specific survival.
RkJQdWJsaXNoZXIy MTk4NDMw